MedTrace Logo

European CMR Registry

NCT01197677 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30000

Last updated 2016-09-07

No results posted yet for this study

Summary

1. The main aim of the first specific protocol initiated by the European CMR registry, suspected CAD, is to demonstrate that patients presenting for work up of suspected coronary artery disease, which have a completely normal CMR scan will have a low risk for cardiovascular events.
2. The main aim of the second specific protocol initiated by the European CMR registry, HCM-SCD, will be to evaluate CMR for risk stratification in hypertrophic cardiomyopathy(HCM).
3. This registry is sought to collect data on the general use of CMR in the European clinical practice, its safety and its therapeutic implications in a high number of cases to 1) substantiate the clinical yield of CMR and 2) to define additional clinical questions worth to be investigated in detail as additional specific protocols in the future.

Conditions

  • Consecutive Patients Undergoing CMR

Sponsors & Collaborators

  • Stiftung Institut fuer Herzinfarktforschung

    lead OTHER

Principal Investigators

  • Heiko Mahrholdt, MD · Robert-Bosch-Medical-Center, Stuttgart, Germany

  • Oliver Bruder, MD · Elisabeth-Hospital, Essen, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2009-09-30
Completion
2013-10-31

Countries

  • Germany
  • Italy
  • Spain
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01197677 on ClinicalTrials.gov